EORTC embarked on a membership renewal programme
5 Feb 2021
In 2020, EORTC embarked on an ambitious membership renewal programme, in order to comply with GDPR regulation and to ensure that all information of its members are up to date. Following this renewal programme, EORTC can confirm over 2800 direct members coming from 730 institutions. The network comprises of members coming from 48 countries around the world, with the top ten from Europe.
EORTC is a truly multidisciplinary organisation of which 15% are organ specialists. Its membership spans over 30 different disciplines conducting clinical research.
“One of the uniqueness of EORTC is that we conduct trials across multiple tumours and the members are stratified across groups related to their tumour of interest. We are able to attract leading clinical researchers across the globe, conducting practice changing trials,” said Denis Lacombe, EORTC Director General. “As EORTC approaches its 60th anniversary next year, we remain fully committed to all cancer patients, our members, partners and supporters, ensuring the organisation stays true to its mission and paves the way to innovation in cancer care.”
Related News
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
11 Dec 2024
Minister F. Vandenbroucke visits EORTC Headquarters to strengthen collaborative efforts in clinical cancer research
21 Nov 2024
IMMUcan has completed patient enrolment
12 Nov 2024
EORTC SPRINT clinical cancer study receives support from Rising Tide Foundation to reduce the burden for patients
5 Nov 2024
Pink October at EORTC: Over 60 years of impactful breast cancer research
29 Oct 2024
Spotlight on ENA 2024 News
25 Oct 2024
Do regulations and policies undermine the social value of independent academic research?
25 Oct 2024
EORTC Quality of Life Group’s participation to ISOQOL 2024
10 Oct 2024
New Insights into Glioblastoma Treatment for Older Adults Patients
8 Oct 2024
TOPGEAR trial results show no significant benefit of preoperative chemoradiotherapy on long term survival
24 Sep 2024